FMO5 and Alzheimer disease: Together, this suggests that increases in NOX activity participate in early AD pathogenesis and contribute to AD progression due to massive ROS production initiated by NADPH oxidases, activating signaling pathways leading to neuronal excitotoxicity and glial cell-mediated inflammation (12).